News – Project Breathing Hope

Highlights from 2nd Annual Lung Cancer Action Network

Post author:admin
Post published:December 22, 2020
Post category:News Research

PATIENTS driving RESEARCH to SAVE LIVES Highlights from 2nd Annual Lung Cancer Action Network (LungCAN) Meeting Fundraising = Research = Survival Day on Capitol Hill The Go2 Lung Cancer Foundation…

Barrington native battles lung cancer

Post author:admin
Post published:April 5, 2020
Post category:News

Barrington native battles lung cancer Dr. Jennifer (Zannini) Cipriani builds fund-raising page Barrington native Dr. Jennifer Cipriani poses for a photo with her family, husband Matt and children Charlotte and…

Health Check

Post author:admin
Post published:December 13, 2019
Post category:News

Health Check: Doctor diagnosed with terminal lung cancer finds new passion by BARBARA MORSE, NBC 10 NEWSFriday, December 13th 2019 After being diagnosed with terminal lung cancer three years ago,…

• How many people? 155,000 Americans lose their lives to lung cancer each year. • The #1 killer. Lung cancer is the leading cancer killer of both men and women in the U.S. (second only to heart disease in overall cause of death) • Research funding needed. Lung cancer receives only $1,831 in federal research funds per death, compared to $4,582 for colorectal cancer and $13,406 for breast cancer. • Not just a “smokers’s disease.” Around 70% of lung cancer victims are never-smokers (100 or fewer cigarettes smoked over a lifetime1). • Women at greater risk. Lung cancer is the leading cause of cancer death in women, killing more women each year than breast cancer, uterine cancer, and ovarian cancer combined. Two-thirds of never-smokers who develop lung cancer are women. • Survival. Lung cancer currently has only a 5-year overall survival rate of 5-20%, shockingly low compared to the next three most common cancers (breast, prostate and colon), which now have 5-year survival rates approaching 80 – 90%, thanks to research funding. • Lack of early detection. 41% of patients diagnosed with non-small cell lung cancer (NSCLC) are not diagnosed until Stage IV.1 EGFR-Positive Lung Cancer • Prevalence. Around 15% of all lung cancer patients in the U.S. are diagnosed with EGFR-positive (EGFR+) lung cancer, with prevalence among people of Eastern Asian descent much higher, between 35 – 50%. • Never-smokers. Lung cancers in non-smokers and never-smokers are far more likely to express the EGFR+ mutation. • Populations at greatest risk. EGFR+ is more common among: never-smokers and non-smokers; women than men; people of East Asian heritage; Caucasians than African Americans; young adults. (Roughly 50% of young adults with lung cancer have EGFR mutations.) —————————————- 1. Lovly, C., L. Horn, W. Pao. 2015. EGFR in Non-Small Cell Lung Cancer (NSCLC). My Cancer Genome https://www.mycancergenome.org/content/disease/lung-cancer/egfr 2. Zhu QG, Zhang SM, Ding XX, He B, Zhang HQ. Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies. Oncotarget. 2017;8(34):57680-57692. * Other sources of statistics include: American Cancer Society, National Cancer Institute.

See Jen's story on social media.

Helping to Rewrite the Future of Lung Cancer

See Jen's story on social media.

Helping to Rewrite the Future of Lung Cancer

Highlights from 2nd Annual Lung Cancer Action Network

Barrington native battles lung cancer

Health Check

Project Breathing Hope

SHARE

Contact Project Breathing Hope Today

Help to Rewrite the Future of Lung Cancer

FOUNDATION

GET INVOLVED